Susquehanna International Group, LLP Cara Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$568 Billion
Q1 2024

Call Options

26 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	SELL	$0.6 - $1.65 $480 - $1,320	-800 Reduced 5.59%	13,500 $9,000
Q3 2023 Nov 14, 2023	SELL	$1.67 - $3.33 $20,040 - $39,960	-12,000 Reduced 45.63%	14,300 $24,000
Q2 2023 Aug 11, 2023	SELL	$2.83 - $4.94 $56,317 - $98,306	-19,900 Reduced 43.07%	26,300 $74,000
Q1 2023 May 16, 2023	SELL	$4.89 - $12.27 $107,091 - $268,713	-21,900 Reduced 32.16%	46,200 $226,000
Q4 2022 Feb 14, 2023	SELL	$8.88 - $12.77 $14,208 - $20,432	-1,600 Reduced 2.3%	68,100 $731,000

Q3 2022 Nov 14, 2022	BUY	$8.24 - $12.56 $394,696 - $601,624	47,900 Added 219.72%	69,700 $652,000
Q2 2022 Aug 15, 2022	SELL	$7.45 - $13.84 $362,815 - $674,008	-48,700 Reduced 69.08%	21,800 $199,000
Q1 2022 May 16, 2022	BUY	$9.94 - $12.65 $402,570 - $512,325	40,500 Added 135.0%	70,500 $857,000
Q4 2021 Feb 14, 2022	SELL	$11.99 - $18.14 $2.55 Million - $3.85 Million	-212,300 Reduced 87.62%	30,000 $365,000
Q3 2021 Nov 15, 2021	BUY	$11.55 - $16.06 $1.82 Million - $2.53 Million	157,300 Added 185.06%	242,300 $3.74 Million
Q2 2021 Aug 11, 2021	SELL	$12.38 - $29.19 $689,566 - $1.63 Million	-55,700 Reduced 39.59%	85,000 $1.21 Million
Q1 2021 May 17, 2021	SELL	$15.07 - $21.71 $822,822 - $1.19 Million	-54,600 Reduced 27.96%	140,700 $3.06 Million
Q4 2020 Feb 16, 2021	BUY	$12.72 - $16.16 $200,976 - $255,328	15,800 Added 8.8%	195,300 $2.96 Million
Q3 2020 Nov 16, 2020	SELL	$12.34 - $17.92 $1.02 Million - $1.48 Million	-82,800 Reduced 31.57%	179,500 $2.28 Million
Q2 2020 Aug 14, 2020	BUY	$12.39 - $17.33 $1.38 Million - $1.93 Million	111,200 Added 73.59%	262,300 $4.49 Million
Q1 2020 May 15, 2020	SELL	$9.12 - $17.78 $1.28 Million - $2.5 Million	-140,600 Reduced 48.2%	151,100 $2 Million
Q4 2019 Feb 14, 2020	BUY	$16.11 - $25.98 $971,433 - $1.57 Million	60,300 Added 26.06%	291,700 $4.7 Million
Q3 2019 Nov 14, 2019	SELL	$18.28 - $26.91 $5.29 Million - $7.79 Million	-289,600 Reduced 55.59%	231,400 $4.23 Million
Q2 2019 Aug 14, 2019	BUY	$17.68 - $21.57 $5.95 Million - $7.25 Million	336,300 Added 182.08%	521,000 $11.2 Million
Q1 2019 May 15, 2019	BUY	$14.41 - $19.64 $2.27 Million - $3.09 Million	157,400 Added 576.56%	184,700 $3.62 Million
Q4 2018 Feb 14, 2019	SELL	$12.45 - $23.47 $1.47 Million - $2.76 Million	-117,800 Reduced 81.19%	27,300 $355,000
Q3 2018 Nov 14, 2018	SELL	$17.57 - $23.95 $2.65 Million - $3.62 Million	-151,000 Reduced 51.0%	145,100 $3.48 Million
Q2 2018 Aug 14, 2018	BUY	$11.6 - $19.27 $1.7 Million - $2.83 Million	146,900 Added 98.46%	296,100 $5.67 Million
Q1 2018 May 15, 2018	BUY	$11.77 - $16.08 $1.06 Million - $1.45 Million	89,900 Added 151.6%	149,200 $1.85 Million
Q4 2017 Feb 14, 2018	SELL	$11.86 - $14.08 $1.68 Million - $2 Million	-141,800 Reduced 70.51%	59,300 $726,000
Q3 2017 Nov 14, 2017	BUY	$12.6 - $16.34 $2.53 Million - $3.29 Million	201,100	201,100 $2.75 Million

Others Institutions Holding CARA

# of Institutions

102

Shares Held

21.5M

Call Options Held

50K

Put Options Held

Black Rock Inc. New York, NY

3.42M
Shares

$1.13 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.48M
Shares

$818,815
0.0% of portfolio
Disciplined Growth Investors Inc Minneapolis, MN

1.82M
Shares

$598,969
0.03% of portfolio
Chescapmanager LLC Baltimore, MD

1.7M
Shares

$561,696
0.15% of portfolio
Farallon Capital Management LLC San Francisco, CA

1.56M
Shares

$513,562
0.01% of portfolio

View Full List

About Cara Therapeutics, Inc.

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $17.7M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

More about CARA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account